Locus: Rv0647c (Chromosome position: 741,151–742,617 bp, reverse strand)
Length: 488 amino acids
Functional Category: Conserved hypothetical protein with unknown enzymatic activity .
Homology: Shares similarity with ABC1-like proteins in Mycobacterium leprae (NP_302277.1) and Synechocystis (P73627) .
Contains a conserved ABC1 domain, suggesting potential involvement in protein kinase activity or ATP binding .
| Compartment | Detection Method | Study |
|---|---|---|
| Membrane | 1D-SDS-PAGE, nanoLC-MS/MS | Gu et al., 2003 |
| Cell Wall | 2DLC/MS | Mawuenyega et al., 2005 |
| Cytosol | Triton X-114 extraction | Malen et al., 2010 |
Conflicting mutagenesis data:
Amino Acid Sequence: Begins with MRAEIGPDFR... (full sequence available in UniProt P9WQI0) .
Storage: Lyophilized form stable for 12 months at -20°C/-80°C .
Vaccine Development: Investigated as a subunit vaccine candidate due to surface localization in M. tuberculosis .
Host-Pathogen Interaction Studies: Membrane association suggests potential roles in cell envelope integrity or signaling .
STRING database analysis reveals interactions with proteins involved in lipid metabolism and cell wall synthesis :
| Partner Gene | Function | Interaction Score |
|---|---|---|
| lipG (Rv0646c) | Lipase/esterase activity | 0.996 |
| mmaA1 | Mycolic acid methylation | 0.881 |
| Rv0648 | Alpha-mannosidase | 0.586 |
Rv0647c (also known as MT0675) is an uncharacterized protein from Mycobacterium tuberculosis, the causative agent of tuberculosis . As an uncharacterized protein, its precise function, structure, and role in M. tuberculosis biology have not been fully determined. Current research approaches typically combine bioinformatics analysis, structural characterization, and functional assays to elucidate the biological significance of such proteins within the context of M. tuberculosis pathogenesis.
According to available data, recombinant Rv0647c (aa 1-488) can be expressed in several heterologous systems including E. coli, yeast, baculovirus, and mammalian cell cultures . The selection of an expression system should be guided by research objectives:
E. coli systems offer high yield and cost-effectiveness but may lack post-translational modifications
Yeast provides eukaryotic processing capabilities with moderate yield
Baculovirus expression is advantageous for larger proteins requiring specific folding environments
Mammalian cell systems deliver the most authentic post-translational modifications
For initial characterization studies, E. coli expression is typically attempted first due to its simplicity and scalability, before progressing to more complex systems if functionality issues arise.
While the search results don't provide specific information about Rv0647c's relationships to other proteins, researchers investigating uncharacterized mycobacterial proteins typically examine genomic context and potential functional relationships. M. tuberculosis contains several well-studied gene clusters involved in cell wall biosynthesis, such as the mmaA1-mmaA2-mmaA3-mmaA4 genes that participate in mycolic acid modifications . Understanding the proximity of Rv0647c to these clusters and analyzing sequence homology patterns may provide insights into its potential functional associations.
When designing experiments to characterize uncharacterized proteins like Rv0647c, researchers should follow structured experimental design principles addressing the five key areas of difficulty identified in research design literature :
Define experimental subject properties - clearly characterize the recombinant protein and expression system
Establish manipulated variables - determine which conditions or treatments will be systematically altered
Identify appropriate measurement outcomes - select assays that can detect potential functions
Account for variability - implement proper controls and replication
Consider the scope of inference - understand the limitations of experimental findings
A systematic experimental approach should include:
Bioinformatic prediction of potential functions
Gene knockout or knockdown studies
Protein localization determination
Interaction partner identification
Structural analysis through crystallography or cryo-EM
Experimental design validation when studying uncharacterized proteins like Rv0647c requires rigorous assessment across multiple criteria. According to experimental design rubrics , researchers should ensure:
These validation steps help researchers avoid common pitfalls in experimental design that have persisted in biological research for decades .
For uncharacterized proteins like Rv0647c, comprehensive bioinformatic analysis forms the foundation for functional hypothesis generation. A multi-layered approach should include:
| Analysis Type | Methods | Expected Outcomes |
|---|---|---|
| Sequence-based analysis | BLAST searches, Multiple sequence alignment, HMM profile searches | Identification of homologous proteins, conserved domains, functional motifs |
| Structural prediction | Secondary structure prediction, Homology modeling, AlphaFold2 prediction | Potential structural features, active sites, binding pockets |
| Genomic context analysis | Gene neighborhood analysis, Operon prediction | Functional associations, metabolic pathway connections |
| Evolutionary analysis | Phylogenetic profiling, Selective pressure analysis (dN/dS ratios) | Evolutionary conservation, potential essential functions |
Integration of these computational approaches generates testable hypotheses about Rv0647c function that can guide subsequent experimental validation strategies.
Given the critical importance of mycolic acids in M. tuberculosis pathogenesis , investigating whether Rv0647c plays a role in cell wall biosynthesis requires a systematic experimental approach:
Generate genetic manipulation strains:
Create precise Rv0647c knockout mutants
Develop complemented strains expressing wild-type Rv0647c
Perform comprehensive lipid profiling:
Assess cell wall integrity:
Examine cell envelope structure through electron microscopy
Test susceptibility to cell wall-targeting antibiotics
Conduct permeability assays with hydrophobic compounds
Investigate potential interactions with known cell wall biosynthesis proteins:
These experimental approaches would generate comprehensive evidence regarding any potential role of Rv0647c in mycolic acid biosynthesis or broader cell wall formation.
Purifying mycobacterial proteins for structural studies presents specific challenges that require methodological solutions:
These methodological considerations are essential for obtaining purified Rv0647c suitable for downstream structural biology applications such as X-ray crystallography or cryo-electron microscopy.
Understanding the protein interaction network of uncharacterized proteins like Rv0647c provides crucial functional insights. Researchers should implement a multi-faceted proteomics strategy:
Affinity-based methods:
Express epitope-tagged Rv0647c in mycobacterial cells
Perform co-immunoprecipitation followed by mass spectrometry
Use crosslinking agents to capture transient interactions
Implement proximity-dependent labeling technologies (BioID, APEX)
Validation techniques:
Bacterial two-hybrid screening
Direct binding assays (surface plasmon resonance, isothermal titration calorimetry)
Co-localization studies with fluorescently tagged proteins
Bioinformatic integration:
Incorporate protein co-expression data
Analyze genomic context alongside proteomics results
Predict functional associations through network analysis
This comprehensive approach helps establish the interaction landscape of Rv0647c, potentially revealing its functional role within M. tuberculosis biology.
When studying mycobacterial proteins, researchers must consider genetic diversity across M. tuberculosis lineages. As demonstrated with other M. tuberculosis genes like mmaA3 (Rv0643c), lineage-specific mutations can significantly impact protein function . For Rv0647c research:
Perform comparative genomic analysis:
Analyze Rv0647c sequences across diverse clinical isolates and reference strains
Identify single nucleotide polymorphisms (SNPs) or other genetic variations
Determine if variations are conserved within specific lineages
Assess whether variations impact protein structure or function using predictive tools
Consider experimental implications:
Include multiple strain backgrounds in functional studies
Test complementation with variant alleles
Evaluate phenotypic differences across lineages
This approach ensures research findings about Rv0647c are appropriately contextualized within M. tuberculosis diversity and evolution, similar to studies of mmaA3 gene variants that revealed lineage-specific functional differences .
For academic researchers investigating the potential of Rv0647c as a diagnostic or vaccine candidate, several methodological considerations are critical:
Antigenicity assessment:
Analyze sequence conservation across clinical isolates
Identify potential B-cell and T-cell epitopes through computational prediction
Test immunogenicity in appropriate animal models
Specificity determination:
Perform comparative genomics against non-tuberculous mycobacteria
Assess cross-reactivity with human proteins
Evaluate specificity in diverse clinical sample testing
Accessibility validation for diagnostics:
Determine cellular localization of Rv0647c
Assess expression levels during different growth phases and in various infection models
Evaluate presence in patient samples (sputum, blood, urine)
Immunological characterization for vaccine research:
Map T-cell and B-cell epitopes experimentally
Assess protective immunity in appropriate animal models
Evaluate safety through comprehensive immunopathology studies
These methodological considerations provide a scientific framework for evaluating the diagnostic and vaccine potential of Rv0647c, focusing on the research methodology rather than commercial applications.
Investigating potential virulence contributions of uncharacterized proteins like Rv0647c requires carefully controlled experimental designs that address the five key areas of experimental design difficulty :
Generate appropriate genetic manipulation strains:
Create precise Rv0647c knockout mutants using specialized mycobacterial genetic tools
Develop complemented strains expressing wild-type Rv0647c
Create point mutation variants for structure-function analysis
Implement a multi-level virulence assessment approach:
In vitro cellular models: Macrophage infection assays (survival, replication)
Ex vivo tissue models: Granuloma-like structures
In vivo infection models: Mouse infection studies with bacterial burden and histopathology assessment
Apply comprehensive readouts:
Bacterial survival and replication metrics
Immune response parameters (cytokine profiles, cell recruitment)
Tissue damage and pathology scoring
Account for variability through:
Appropriate sample sizes based on power calculations
Multiple biological and technical replicates
Controls for genetic background effects
This systematic approach allows researchers to establish whether Rv0647c contributes to virulence and to characterize the mechanisms involved while adhering to sound experimental design principles .
When investigating uncharacterized proteins like Rv0647c, researchers often encounter contradictory results across different experimental systems or approaches. Methodological strategies to resolve such contradictions include:
Systematic validation across multiple experimental systems:
Control for experimental variables that might cause contradictions:
Protein expression levels and localization
Growth conditions and physiological state
Genetic background effects
Implement orthogonal experimental approaches:
Combine genetic, biochemical, and structural methods
Use both gain-of-function and loss-of-function approaches
Employ both in vitro and in vivo systems
Apply the experimental design rubric to identify potential methodological issues :
Review variable properties consideration
Examine measurement approaches
Reassess variability management
This methodological framework helps researchers resolve apparent contradictions and develop a coherent understanding of Rv0647c function.
Researchers investigating Rv0647c can access various specialized tools and resources:
These resources provide researchers with the specialized tools needed to comprehensively study this uncharacterized protein and place findings within the broader context of M. tuberculosis biology.
Current limitations in studying uncharacterized mycobacterial proteins like Rv0647c include:
Functional annotation challenges:
Methodological solution: Implement comprehensive bioinformatic pipelines combining sequence, structure, and genomic context analysis
Apply high-throughput phenotypic screening approaches across diverse conditions
Difficulty in establishing essentiality:
Methodological solution: Use conditional knockdown systems rather than direct knockout
Implement CRISPRi approaches with inducible repression
Challenges in structural characterization:
Methodological solution: Utilize hybrid approaches combining crystallography, cryo-EM, and computational modeling
Express protein domains separately if full-length protein proves recalcitrant
Limited understanding of in vivo relevance:
Methodological solution: Develop more physiologically relevant infection models
Implement tissue-specific expression analysis during various infection stages
Experimental design limitations:
These methodological approaches help researchers overcome current limitations and advance understanding of Rv0647c's function in M. tuberculosis biology.